Table 1. Treatment planning objectives used by dosimetrist to generate the treatment plan for this patient. The lower number in the fifth column indicates higher priority.
Target and Critical Normal Tissue Constraints | ||||
Structure Name | DVH Objective | Evaluator | Variation Acceptable | Priority |
PTVeval_BREAST | D95%[Gy] | ≥ 40.4 | ≥ 38.3 | 1 |
PTVeval_BREAST | V90%[%] | ≥ 99 | ≥ 98 | 2 |
PTVeval_BREAST | V105%[%] | ≤ 10 | ≤ 15 | 2 |
PTVeval_BREAST | Max[%] | ≤ 107 | ≤ 110 | 1 |
BREAST_CONTRA | D5%[Gy] | ≤ 2 | ≤ 3 | 3 |
LUNG_IPSI | V20Gy[%] | ≤ 15 | ≤ 20 | 2 |
LUNG_IPSI | V5Gy[%] | ≤ 50 | ≤ 55 | 2 |
LUNG_CONTRA | V5Gy[%] | ≤ 10 | ≤ 15 | 3 |
HEART | V20Gy[%] | ≤ 2 | ≤ 5 | 2 |
HEART | Mean[Gy] | ≤ 3 | ≤ 4 | 2 |